Gilead paid $11 billion in late 2011 for the right
Post# of 152114
(Total Views: 518)
Posted On: 03/13/2025 5:29:16 PM
Quote:
Gilead paid $11 billion in late 2011 for the rights to market Sovaldi, an amount it totally recouped in its first year of sales after approval of the drug in late 2013.”
$11B for one indication...in 2013!
Holeeeee schnikeees - CYDY puts that to shame.
Dr. J et. al. - bring us a BIG number por favor...
...and STAT, 'cuz patience is not my core competence.
(8)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼